Target intelligence / Profile preview

Stress-induced ligands (NKG2D and DNAM-1 ligands) (SILs)

Target
SILs
Molecular classification
MHC class I-related protein, Immunoglobulin superfamily, Cell surface glycoprotein
01

Overview

Stress-induced ligands (SILs) are a diverse group of cell surface proteins, including MICA/B, ULBPs, CD155, and CD112, that are upregulated on cells undergoing malignant transformation, viral infection, or DNA damage (Dhar & Wu, 2018). These ligands serve as critical recognition signals for the immune system by binding to activating receptors such as NKG2D and DNAM-1 (CD226) expressed on Natural Killer (NK) cells and certain T cell subsets (Shimasaki et al., 2020). In the context of CYNK-001, an allogeneic, placental-derived NK cell therapy, these ligands are the primary targets that facilitate the recognition and lysis of tumor cells (Celularity, 2024). CYNK-001 is enriched for NK cells that express high levels of these activating receptors to effectively engage with the stress ligands present on various hematologic and solid tumors (Sanchez-Correa et al., 2019). Upon binding, the NK cells undergo degranulation, releasing cytotoxic molecules like perforin and granzymes to induce apoptosis in the target cell. However, tumors often employ immune evasion strategies, such as the proteolytic shedding of MICA/B, which creates soluble decoys that can impair NK cell function (Zingoni et al., 2018). Understanding the density and variety of these ligands on target cells is essential for predicting the efficacy of CYNK-001 and similar NK-based immunotherapies.

Other names
NKG2D ligandsDNAM-1 ligandsMICAMICBULBP1-6CD155CD112PVRNectin-2Stress ligand–binding NK activating receptors on CYNK-001 – target cell ligands
02

Mechanism of action

Activation of NK cell-mediated cytotoxicity through the engagement of activating receptors (NKG2D, DNAM-1) with their respective stress-induced ligands on target cells.

03

Biological functions

Immune responseNK cell activationCell death inductionStress signaling
04

Disease associations

CancerInfection
05

Safety considerations

Ligand shedding (immune evasion)Potential off-target effects on stressed healthy tissueDecoy receptor interference
06

Interacting drugs

CYNK-001

3 more in the full profile.

07

Biomarkers

Surface expression of MICA/BULBP expressionCD155/CD112 expressionSoluble MICA levels

Beyond the preview

Go deeper on Stress-induced ligands (NKG2D and DNAM-1 ligands) (SILs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stress-induced ligands (NKG2D and DNAM-1 ligands) (SILs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call